Estropipate

In the US, Estropipate (estropipate systemic) is a member of the drug class estrogens and is used to treat Atrophic Urethritis, Atrophic Vaginitis, Hypoestrogenism, Oophorectomy, Osteoporosis, Postmenopausal Symptoms and Primary Ovarian Failure.

US matches:

• Estropipate


• Estropipate (Piperazine Estrone Sulfate)

Scheme

BAN

CAS registry number (Chemical Abstracts Service)

0007280-37-7

Chemical Formula

C22-H32-N2-O5-S

Molecular Weight

436

Therapeutic Category

Estrogen

Chemical Name

Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1)

Foreign Name

• Estron 3-hydrogensulfat, Piperazinsalz (German)

Generic Names

• Estropipate (OS: BAN)
• Estropin (IS)
• Piperazine Estrone Sulfate (IS)
• Piperazine oestrone sulfate (IS)
• Estropipate (PH: USP 30, BP 2010)

Brand Names

• Estropipate
  Mylan, United States; Teva USA, United States; Watson, United States



• Genoral
  Pfizer, Australia



• Harmogen
  Pfizer, United Kingdom



• Ogen
  Pfizer, Australia; Pfizer, Canada; Pfizer, United States



• Ortho-Est
  Janssen-Cilag, South Africa; Sun, United States

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.